Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Dreamegg Unveils Sunrise Alarm Clocks -- Up to 42% Off for Winter Mornings and…
Leading this year's promotion is the Sunrise 1, offering the strongest discount of the event. Designed for users who prefer an easy, screen-free routine, it features intuitive button control, a soft sunrise simulation, relaxing white-noise options, and a warm glow that helps you wake naturally — even during the darkest winter weeks. Leading this year's promotion is theSunrise 1, offering the strongest discount of the event. Designed for users who prefer an easy, screen-free routine, it...
PR Newswire
19/11/2025
Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid…
Tsingke Biotech combines advanced gene synthesis, automated expression, and purification technologies to deliver rapid protein production. The company supports six expression systems—including E. coli, Bacillus subtilis, yeast, insect, mammalian, and cell-free systems—allowing simple proteins to be produced in 3 days via cell-free methods, while complex proteins and antibodies are ready in 7–14 days. According to Tsingke, overall protein expression success reaches 95%. Tsingke Biotech…
PR Newswire
19/11/2025
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging…
Amsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership withCortechs.ai, a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The collaboration strengthens Philips’...
Nasdaq GlobeNewswire
19/11/2025
New Survey Reveals Ongoing Communication Barriers for Deaf and Hard-of-Hearing…
The majority of both Deaf participants (62%) and Hard-of-Hearing participants (66%) reported that communication barriers impacted their career decisions, limiting job opportunities and professional growth. The need to rely on regular assistance from hearing individuals in work-related communications remains a major obstacle for both groups, preventing them from fully participating or maximizing their potential in the workforce. The majority of both Deaf participants(62%)and Hard-of-Hearing...
PR Newswire
19/11/2025
Sapphiros announces a strategic agreement with Roche, providing Roche access to…
Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab quality performance to point-of-care and home self-testing. Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab...
PR Newswire
19/11/2025
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry…
First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs Teva's first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth StrategyRise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact across Teva's global ecosystem including in the U.S., Europe, Israel and beyondTEL...
Nasdaq GlobeNewswire
19/11/2025
GUERBET : Financial agenda for 2026
Financial agenda for 2026Villepinte, November 19, 2025:Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026. Publications calendar 2025 ANNUAL REVENUE February 05, 2026,after trading2025 ANNUAL RESULTSMarch 11, 2026, after trading2026 1ST QUARTER REVENUE April 23, 2026,after tradingANNUAL SHAREHOLDERS’ MEETING May 22, 2026 2026 2ND QUARTER...
Nasdaq GlobeNewswire
19/11/2025
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in…
Curium has entered a partnership with the Czech company ÚJV Řež, a leading expert in the development and production of radiopharmaceuticals, to manufacture diagnostic radiopharmaceuticals for patients with prostate cancer in both Czech Republic and Slovakia This will provide solutions to a wider patient group across both countries where there is high demand and unmet needPARIS, Nov.19, 2025(GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, has announced that patients...
Nasdaq GlobeNewswire
19/11/2025
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing…
Gene editing of HSPCs offers the potential for long-term therapeutic benefit. While viral vectors such as AAV6 are commonly used for gene insertion, they raise safety and efficacy concerns. Over the past decade, non-viral DNA templates delivery has emerged as promising alternatives and have been used with nucleases to target short single-stranded linear DNA corrective template in HSPCs. Although non-viral approaches were initially limited to making only small corrections within defective...
Nasdaq GlobeNewswire
19/11/2025
One Device for Your Essential Home Inspection Needs -- Raythink's EX10 Launches…
A Tool Designed for Essential Home Inspection Need A Tool Designed for EssentialHome Inspection Need The EX10 offers fast, contact-free, precise inspections. Its infrared imager highlights temperature differences, identifies hidden defects, and supports in-depth analysis across home inspection scenarios: Winter: The Optimal Season for Home Inspection Winter is the ideal time for a home inspection. The contrast between indoor heating and cold outdoor temperatures makes issues...
PR Newswire
19/11/2025
KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer…
Compact Footprint and Workflow Efficiency Compact Footprint and Workflow Efficiency Despite its small 0.36 m² footprint, the Polaris V150 delivers 150 tests per hour, enabling laboratories to achieve high operational efficiency within limited workspace. It supports continuous loading of samples, reagents, and reaction cups, while its STAT function ensures urgent samples are prioritized for rapid clinical decision-making. The system offers 40 sample positions, accommodates serum and plasma,...
PR Newswire
19/11/2025
European study shows falling prices, rising costs and shortages - findings from…
In the context of AMR Awareness Week, Viatris Inc. (Nasdaq: VTRS), a global healthcare company, with Medicines for Europe – the voice of the generic, biosimilar, and value-added medicines industries in Europe – present findings from a from an independent study by New Angle, a consulting and research agency, investigating the reasons behind shortages of essential off-patent medicines, with a particular focus on antibiotics. In the context of AMR Awareness Week,Viatris Inc. (Nasdaq: VTRS), a...
PR Newswire
19/11/2025
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives…
As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and manufacturing facility, Grangemouth offers comprehensive solutions for bioconjugates, from process development to scale-up. The site also plays a critical role in the ADCelerate™ program, which streamlines the path from R&D to GMP production to bring lifesaving bioconjugate therapies to patients in the clinic faster. As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and...
PR Newswire
19/11/2025
Essity awarded EcoVadis Platinum medal for outstanding sustainability leadership…
EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability rating reflects comprehensive policies on all key areas, including disclosure on progress toward the UN Sustainable Development Goals (SDGs). EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability...
PR Newswire
19/11/2025
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or…
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses 1,2 Lunsumio subcutaneous offers a new treatment option that can significantly reduce administration time to approximately one minuteAvailability of Lunsumio SC allows patients to receive treatment aligned to clinical requirements and lifestyle preferencesBasel, 19 November 2025 - Roche (SIX: RO,...
Nasdaq GlobeNewswire
19/11/2025
Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving…
Addressing the Critical Window to Save Lives Addressing the Critical Window to Save Lives Uncontrolled bleeding is the leading cause of preventable death following trauma, whether caused by accidents, mass-casualty events or in the battlefield. Caregivers need a tool which can be easily administered to a large number of casualties in a short period of time. TXA is an antifibrinolytic agent commonly used off label around the world to treat trauma bleeding in the pre-hospital and...
PR Newswire
19/11/2025
Wearable Medical Devices Market Will reach $184.75 billion by 2033 - Strategic…
This surge is also being fuelled by a fundamental shift in patient expectations. Individuals want more visibility into their own health metrics, and healthcare systems-facing workforce shortages and rising costs-need technologies that improve monitoring efficiency without compromising care quality. Against this backdrop, wearable medical devices have emerged as a cornerstone of the modern healthcare ecosystem, offering unprecedented data precision, clinical relevance, and accessibility. This...
PR Newswire
19/11/2025
New data on lecanemab to be presented at CTAD conference
Key lecanemab poster presentation: Key lecanemab poster presentation: Real-world experience: During the poster session onMonday, Dec. 1, at3:00 PM PTandTuesday, Dec. 2, at5:30 PM PT, Poster 055 presents an overview of baseline characteristics and preliminary safety findings from a study of lecanemab in Alzheimer's disease (AD) using the ALZ-NET registry. Additional lecanemab poster presentations Leqembi is the result of a long-standing collaboration between BioArctic...
PR Newswire
19/11/2025
Europe must embed patient voices to transform digestive health outcomes, urges…
"Digestive diseases affect millions of people across Europe and place significant strain on patients, families, and healthcare systems," said Professor Patrizia Burra, Chair of the UEG Public Affairs Group. "This manifesto calls for a culture of partnership – where patients' lived experiences guide research priorities, policy decisions, and clinical practice." "Digestive diseases affect millions of people acrossEuropeand place significant strain on patients, families…
PR Newswire
19/11/2025
Osteoporosis Market Set to Expand Significantly During the Forecast Period…
Osteoporosis Market Summary Osteoporosis Market Summary Discover the osteoporosis new treatment @New Treatments for Osteoporosis Key Factors Driving the Growth of the Osteoporosis Market Rising Prevalence of Osteoporosis The global burden of osteoporosis is increasing rapidly due to the growing elderly population, especially among postmenopausal women. As life expectancy rises, the prevalence of age-related bone loss and fragility fractures continues to drive the...
PR Newswire
18/11/2025
Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
18/11/2025
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…
Attachment notification-of-managers-transaction-lionel-carnot-november 2025
Nasdaq GlobeNewswire
18/11/2025
Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior…
Media ReleaseCOPENHAGEN, Denmark; November 18, 2025Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that it and its wholly owned subsidiary Genmab Finance LLC (“Genmab Finance”) have priced their previously announced offering of $1.5 billion of 6.250% senior secured notes due 2032 (the “Secured Notes”) and $1.0 billion of 7.250% senior unsecured notes due 2033 (the “Unsecured Notes,” and together with the Secured Notes, the “Notes”). The issue price of the Notes is 100.000%...
Nasdaq GlobeNewswire
18/11/2025
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company AnnouncementCOPENHAGEN, Denmark; November 18, 2025 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:10,033 shares at DKK 1,025.00, 310 shares at DKK 1,147.50, 1,478 shares at DKK 1,161.00, 5,847...
Nasdaq GlobeNewswire
18/11/2025
Altri Comunicati
